Unity Biotechnology, Inc. (UBX)

NASDAQ: UBX · IEX Real-Time Price · USD

1.310

-0.020 (-1.50%)

At close: Jul 2, 2024, 4:00 PM

1.340

+0.030 (2.29%)

After-hours: Jul 2, 2024, 7:08 PM EDT

Unity Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Revenue	0	0.24	4.78	0	0	Upgrade
Revenue Growth (YoY)	-	-95.07%	-	-	-	Upgrade
Gross Profit	0	0.24	4.78	0	0	Upgrade
Selling, General & Admin	18.97	20.95	23.06	24.03	20.05	Upgrade
Research & Development	20.1	36.86	38.39	67.31	70.96	Upgrade
Other Operating Expenses	5.6	0	0	2.6	-1.35	Upgrade
Operating Expenses	44.67	57.81	61.45	93.93	89.65	Upgrade
Operating Income	-44.67	-57.57	-56.67	-93.93	-89.65	Upgrade
Interest Expense / Income	2.45	3.56	3.18	1.29	0	Upgrade
Other Expense / Income	-7.26	-16.66	0.88	-1.38	-7.47	Upgrade
Pretax Income	-39.86	-44.47	-60.73	-93.84	-82.18	Upgrade
Net Income	-39.86	-44.47	-60.73	-93.84	-82.18	Upgrade
Shares Outstanding (Basic)	15	9	6	5	4	Upgrade
Shares Outstanding (Diluted)	15	9	6	5	4	Upgrade
Shares Change	55.60%	70.10%	9.73%	16.60%	54.32%	Upgrade
EPS (Basic)	-2.70	-4.68	-10.88	-18.45	-18.80	Upgrade
EPS (Diluted)	-2.70	-4.68	-10.88	-18.45	-18.80	Upgrade
Free Cash Flow	-36.98	-52.13	-45.26	-78.98	-74.01	Upgrade
Free Cash Flow Per Share	-2.50	-5.49	-8.11	-15.53	-16.96	Upgrade
Gross Margin	-	100.00%	100.00%	-	-	Upgrade
Operating Margin	-	-24394.92%	-1184.47%	-	-	Upgrade
Profit Margin	-	-18842.80%	-1269.34%	-	-	Upgrade
Free Cash Flow Margin	-	-22089.83%	-945.97%	-	-	Upgrade
EBITDA	-36.23	-38.73	-54.67	-89.1	-79.51	Upgrade
EBITDA Margin	-	-16411.44%	-1142.73%	-	-	Upgrade
Depreciation & Amortization	1.18	2.18	2.88	3.45	2.66	Upgrade
EBIT	-37.41	-40.91	-57.55	-92.55	-82.18	Upgrade
EBIT Margin	-	-17335.17%	-1202.93%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).